VISIONEERING TECHNOLOGIES EXPANDS NATURALVUE LENS OFFERINGS
Visioneering Technologies Inc. (VTI) recently introduced its new enhanced NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses with CleanComfort technology. To ensure better comfort, three ingredients have been added to the packaged saline solution, giving the lens what VTI calls a “TripleTear Lubrication System.” The new ingredients include hyaluronic acid (HA), which has been shown to provide superior hydration and lubrication, as well as elements known to lock-in moisture and stabilize tears, according to the company.
The new edge on the NaturalVue Sphere is designed to balance movement for a more optimal fit while still allowing adequate tear exchange to wash away debris, according to the company. There is also a Class 2 UV blocker. Parameters include 8.5mm base curve, 14.2mm diameter, and powers from +4.00D to –12.00D in 0.25D steps.
VTI also recently announced the availability of NaturalVue Multifocal 1 Day Contact Lenses in plus powers. VTI says that this expansion of plus powers gives NaturalVue Multifocal the most extensive power range available of any daily disposable soft multifocal contact lenses currently on the market. The full power range of the lens is now from +4.00D to –12.25D (in 0.25D steps). A further expansion up to +6.00D is planned for the future. Other parameters include 8.3mm base curve, 14.5mm diameter, and a universal extended depth of focus design encompassing up to +3.00D add power. Call (844) VTI-LENS (884-5367) or visit www.vtivision.com . ■
BAUSCH + LOMB OFFERS SCLERAL LENS CARE KIT
Bausch + Lomb’s Specialty Vision Products (B+L SVP) business is launching a scleral lens care kit to provide patients with products to help them apply, remove, and maintain their scleral lenses.
B+L SVP says that the kit provides the components needed for care and application of scleral contact lenses, all in a convenient zipper bag. Contents of the kit include the Boston scleral lens case, a magnifying mirror, application and removal tools, and ScleralFil Preservative Free Saline Solution. The kit is available either with or without a 3.5mL bottle of Boston Simplus Multi-Action Solution.
The kit is available to eyecare professionals and patients for purchase exclusively on www.bauschSVPstore.com . ■
ALLERGAN RELEASES NEW REFRESH FORMULATION
Allergan plc has expanded its Refresh line with the launch of a new over-the-counter (OTC) artificial tear formulation, Refresh Repair Lubricant Eye Drops, which are formulated with carboxymethylcellulose (CMC), hyaluronic acid (HA, an inactive ingredient), and osmoprotectants. Allergan says that these restorative osmoprotectants displace salt in the tear film to safeguard epithelial cells against hyperosmotic stress, thus helping maintain the health of the ocular surface.
Refresh Repair tears are designed to repair and protect the eyes from the harmful effects of dry eye and to improve clarity of vision, according to the company. They are safe to use with contact lenses, and they also have a low incidence of side effects such as blur and stickiness during blinking. Call (800) 678-1605 or visit www.allergan.com . ■
X-CEL SPECIALTY CONTACTS LAUNCHES ATLANTIS SCLERAL PATIENT CARE KIT
X-Cel Specialty Contacts now offers the Atlantis Scleral patient kit, which the company says was designed to assist scleral lens patients in keeping their supplies easily accessible and organized in a travel-sized compact kit. Each mirrored kit contains application and removal tools, unpreserved saline solution, and a contact lens case.
X-Cel says that the patient kits make a perfect addition to practitioners’ scleral lens package and are now available to eyecare professionals through any X-Cel location. Call (800) 241-9312 or visit www.xcelspecialtycontacts.com . ■
REV360 LAUNCHES CLOUD-BASED IMAGE MANAGEMENT SYSTEM
Rev360 recently announced the launch of RevImaging, an image management solution built for and enabled directly within RevolutionEHR. RevImaging provides RevolutionEHR users with an affordable, completely unified, efficient, feature-rich image management solution for better disease progression monitoring, decision making, and overall patient care experiences, according to the company.
Rev360 says that unique to RevImaging is the efficiency that comes from centralized image management. Simultaneous viewing from a wide array of devices provides a seamless experience for reviewing patient images regardless of which equipment or technology originally captured the image(s), according to the company. Visit https://www.rev-360.com/revimaging . ■
RIGHTEYE UNVEILS EYEQ TRAINER
RightEye LLC unveiled its new EyeQ Trainer computer-based vision rehabilitation program. RightEye EyeQ tests are quick, gamified tests that provide information on how a patient’s eyes and brain are working together. The EyeQ Trainer allows eyecare professionals to prescribe targeted, at-home vision exercises to help improve and strengthen areas of weakness. RightEye EyeQ Trainer integrates with EyeQ reports—offering personalized recommendations for improvement for each patient, according to the company.
Through a series of simple exercises conducted on a personal computer or tablet with an internet connection during which patients engage in specific eye movements, RightEye EyeQ Trainer activates the eyes’ muscles as well as key elements of brain circuitry; the circuitry activation results in better functional vision and smoother and more accurate eye movements that directly impact quality of life, according to the company. Exercises take about five minutes per sitting, which the patient does once or twice per day for several weeks. Once patients have completed their prescribed training program, they return to their practitioner’s practice to be retested with the corresponding RightEye EyeQ test. Call (301) 979-7970 or visit www.righteye.com . ■
NOVARTIS LAUNCHES FOCALVIEW APP
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routine of patients, the app may reduce barriers to participation, leading to a more nuanced understanding of ophthalmic diseases and potentially accelerating the development of novel treatments, according to Novartis.
FocalView aims to help patients complete various assessments, gaining feedback on their visual function, including any changes over time. At the same time, the app could provide researchers with a greater volume of real-world, patient-reported data, according to the company. FocalView is now available for download from the App Store in the Unites States. ■
![]({"src":"/media/urgmyiao/cover_cls_0918.jpg","focalPoint":null,"crops":[{"alias":"thumbnail","width":1110,"height":700,"coordinates":null}]})